FDA Grants Supplement Approval for DATSCAN (Ioflupane I-123)
The FDA has granted supplemental approval for DATSCAN, an imaging agent containing Ioflupane I-123.
Therapeutic Area
Therapeutic area intelligence for Imaging Agent with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.